Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for UroGen Pharma (URGN) over the last 10 years, with Q3 2025 value amounting to $46.8 million.

  • UroGen Pharma's Shares Outstanding rose 1088.01% to $46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year increase of 1088.01%. This contributed to the annual value of $42.2 million for FY2024, which is 2998.34% up from last year.
  • According to the latest figures from Q3 2025, UroGen Pharma's Shares Outstanding is $46.8 million, which was up 1088.01% from $46.2 million recorded in Q2 2025.
  • Over the past 5 years, UroGen Pharma's Shares Outstanding peaked at $46.8 million during Q3 2025, and registered a low of $22.3 million during Q1 2021.
  • Over the past 5 years, UroGen Pharma's median Shares Outstanding value was $23.5 million (recorded in 2023), while the average stood at $31.2 million.
  • As far as peak fluctuations go, UroGen Pharma's Shares Outstanding soared by 133.17% in 2021, and later surged by 7520.16% in 2024.
  • Quarter analysis of 5 years shows UroGen Pharma's Shares Outstanding stood at $22.5 million in 2021, then grew by 2.97% to $23.1 million in 2022, then skyrocketed by 40.47% to $32.5 million in 2023, then grew by 29.98% to $42.2 million in 2024, then rose by 10.77% to $46.8 million in 2025.
  • Its Shares Outstanding was $46.8 million in Q3 2025, compared to $46.2 million in Q2 2025 and $46.1 million in Q1 2025.